Παρασκευή 29 Ιουλίου 2016

Single-dose effects on the P3no-go ERP component predict clinical response to stimulants in pediatric ADHD

Attention-deficit hyperactivity disorder (ADHD) is a common developmental disorder involving problems with attention and/or hyperactivity and impulsivity. It is typically identified in childhood, with symptoms often persisting throughout adulthood (Faraone, et al. 2000). Comorbid disorders in behavior, emotion, learning, and autism spectrum are common (Hermens, et al. 2006,American Psychiatric Association. 2013). Prevalence of ADHD is approximately 3%–7% in school-aged children (Willcutt. 2012,Paule, et al.

from Physiology via xlomafota13 on Inoreader http://ift.tt/2aDplOM
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.